Docosahexaenoic Acid in Preventing Recurrence in Breast Cancer Survivors
Conditions: Ductal Breast Carcinoma in Situ; Lobular Breast Carcinoma in Situ; Paget Disease of the Breast; Stage IA Breast Cancer; Stage IB Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast CancerInterventions: Drug: docosahexaenoic acid; Other: placebo; Other: laboratory biomarker analysisSponsor: National Cancer Institute (NCI)Recruiting - verified August 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Carcinoma | Paget Disease of the Nipple | Research